期刊文献+

RT-PCR法检测肾癌组织中MN/CAⅨ基因表达 被引量:1

Detection of carbonic anhydrase Ⅸ gene expression in renal cell carcinoma with reverse transcription-PCR
暂未订购
导出
摘要 目的评价RT-PCR法检测碳酸酐酶Ⅸ(MN/CAⅨ)基因在肾癌组织的表达的可靠性。方法以5例肾癌和5例正常肾组织为研究对象,提取总RNA,两步法进行RT-PCR反应,用MN/CAⅨ的特异性引物扩增,2%琼脂糖凝胶电泳后观察并测序。结果经过测序证实5例肾癌组织的RT-PCR产物中有4例可见特异的MN/CAⅨ条带,而正常肾组织的RT-PCR产物均无相应的MN/CAⅨ条带。结论RT-PCR法检测MN/CAⅨ在肾癌组织中的表达是准确、可靠的。 Objective To evaluate the reliability of reverse transcription (R T) -PCR in detecting the expression of the carbonic anhydrase Ⅸ(MN/CAⅨ) gene in renal cell carcinoma (RCC). Methods MN/CAⅨwas examined in 5 cases of renal cell carcinoma tissues and 5 normal renal tissues. Primers specific for MN/CAⅨwas designed and two-step RT-PCR of the ex-tracted total RNA performed. The products was examined by 2% agrose electrophoresis and identified by sequence nanalysis. Results Specific bands of MN/CAⅨwere found in RT-PCR products of 4 case of RC C tissues, whereas could not be seen in normal renal tissues. Conclusion RT-PCR is reliable for detecting the expression of MN/CAⅨgene in RCC.
出处 《第一军医大学学报》 CSCD 北大核心 2004年第1期99-101,共3页 Journal of First Military Medical University
关键词 RT-PCR法 检测 肾癌 MN/CAⅨ 基因表达 聚合酶链反应 碳酸酐酶Ⅸ carb onic anhydrase Ⅸ(MN/CAⅨ) gene expression renal cell carcinoma/diagnosis pol ymerase chain reaction
  • 相关文献

参考文献2

二级参考文献11

  • 1刘思纯,袁世珍,陈国帧.大肠癌组织树突状细胞与病理特征及预后的关系[J].中山医科大学学报,1996,17(4):260-263. 被引量:9
  • 2李同英 卢晓梅 等.S-100^+树突状细胞在抗肿瘤免疫中的作用与临床意义[J].中国肿瘤生物治疗杂志,1999,6(3):225-225.
  • 3Miller CB, Jones RJ, Piantadosi S, et al. Decreased erythropoietic response in patients with anemia of cancer[J]. New Engl J Med, 1990,322: 1689-95.
  • 4Zucker S, Friedman S, Lysik RM. Bone marrow etythropoiesis in the anemia of infection, inflammation and malignancy[ J ]. J Clin Invest,1974, 53:1132-8.
  • 5Means RT, Dessypris EN, Krantz SB, et al. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon[ J ]. J Cell Physiol, 1992, 150( ): 59-66.
  • 6Means RT, Krants SB, Inhibition of human erythroid colony forming units by gamma interferon can be corrected by recombined human erythropoietin[J]. Blood, 1991,78(10): 2564-73.
  • 7Wood PA, Hrushedy WJ. Cisplatin associated anemia: an erythropoietin deficiency syndrome[J]. J Clin Invest, 1995, 95(4): 1650-61.
  • 8Reed WR, Hussey DH, De Gowing RL, et al. Impfications of the anemia of chronic disorder in patients anticipating radiotherapy[ J ]. Am J Med Sci, 1994, 308(1): 9-13.
  • 9陈红武,黄铮,姚英民.人基因重组促红细胞生成素治疗早产儿贫血的53例临床分析[J].第一军医大学学报,2001,21(7):549-549. 被引量:2
  • 10黄远航.血管紧张素转换酶抑制剂对腹膜透析患者促红细胞生成素浓度的影响[J].第一军医大学学报,2002,22(1):74-75. 被引量:4

共引文献29

同被引文献9

  • 1Stillebroer AB,Mulders PF,Boerman OC. Carbonic anhydrase IX in renal cell carcinoma:implications for prognosis,diagnosis,and therapy[J].European Urology,2010.75-83.
  • 2Zat′ovicová M,Tarábková K,Svastová E. Monoclonal antibodies generated in carbinic anhydrase IX-deficient mice recognize different domains of tumour-associated hyoxia-induced carbonic anhydrase IX[J].Journal of Immunological Methods,2003.117-134.
  • 3Ivanov S,Liao SY,Ivanova A. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer[J].American Journal of Pathology,2001.905-919.
  • 4Pastorekova S,Ratcliffe PJ,Pastorek J. Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia[J].British Journal of Urology International,2008.S8-15.
  • 5Kaluzova M,Pastorekova S,Svastova E. Characterization of the MN/CA9 promoter proximal region:a role for specificity protein(SP)and activator protein 1(AP1 factors)[J].Biochemical Journal,2001.669-667.
  • 6Kaluz S,Kaluzova M,Liao SY. Transcriptional control of the tumor-and hypoxia-marker carbonic anhydrase 9:A one transcription factor(HIF-1)show[J].Biochimica Et Biophysica Acta,2009.162-172.
  • 7Sandlund J,Oosterwijk E,Grankvist K. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma[J].British Journal of Urology International,2007.556-560.
  • 8Leppert JT,Lam JS,Pantuck AJ. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma[J].British Journal of Urology International,2005.281-285.
  • 9Choueiri TK,Regan MM,Rosenberg JE. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy[J].British Journal of Urology International,2010.772-778.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部